{
    "name": "dextrose",
    "comment": "Rx",
    "other_names": [
        "D50W",
        "DGlucose",
        "glucose"
    ],
    "classes": [
        "Glucose-Elevating Agents",
        "Metabolic & Endocrine",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/d50w-dglucose-dextrose-342705",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C/A (oral)",
            "Maternal and fetal hyperglycemia may occur during labor and delivery; monitor",
            "Lactation: Excretion in milk unknown; use with caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Excretion in milk unknown; use with caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Documented hypersensitivity; severe dehydration"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Use caution in DM or carbohydrate intolerance",
                "Give 5% or 10% dextrose to avoid reactive hypoglycemia when highly concentrated dextrose infusion is abruptly withdrawn",
                "An unexpected rise in blood glucose level in a stable patient may be an early symptom of infection; monitor for signs and symptoms of infection and laboratory parameters",
                "Significant hypokalemia may occur from administration of potassium free IV dextrose solutions",
                "Significant hyponatermia or water intoxication may occur from low sodium or sodium-free IV dextrose solution",
                "Use caution in patients with diabetes mellitus; reduce the rate of infusion to reduce the possibilities of causing hyperglycemia and glycosuria",
                "Increased serum osmolality and possible intracerebral hemorrhage may occur from rapid or excessive dextrose administration",
                "Rebound hypoglycemia may occur following abrupt withdrawal",
                "Hypertonic solutions (>10%) may cause thrombosis when infused through peripheral veins; best to infuse through a central venous catherer",
                "Monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged use",
                "Caution advised, to avoid air embolism, when infusing medication",
                "Monitor glucose levels and for possible hyperglycemia when treating pediatric patients",
                "Dextrose injection contains aluminum that may be toxic; patients with impaired renal function, and preterm infants, at higher risk;. limit aluminum to <4 mcg/kg/day",
                "Parenteral nutrition associated with liver disease; increased risk in patients who receive parenteral nutrition for extended periods of time, especially preterm infants; monitor liver function tests, if abnormalities occur consider discontinuation or dosage reduction",
                "Monitor blood glucose and administer insulin as needed"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium chloride",
            "description": {
                "common": "dextrose decreases levels of magnesium chloride by increasing renal clearance. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium citrate",
            "description": {
                "common": "dextrose decreases levels of magnesium citrate by increasing renal clearance. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium hydroxide",
            "description": {
                "common": "dextrose decreases levels of magnesium hydroxide by increasing renal clearance. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium oxide",
            "description": {
                "common": "dextrose decreases levels of magnesium oxide by increasing renal clearance. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium sulfate",
            "description": {
                "common": "dextrose decreases levels of magnesium sulfate by increasing renal clearance. Minor/Significance Unknown."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Hyperosmolarity",
            "percent": null
        },
        {
            "name": "Edema",
            "percent": null
        },
        {
            "name": "Venous thrombosis",
            "percent": null
        },
        {
            "name": "Tachypnea",
            "percent": null
        },
        {
            "name": "Fever",
            "percent": null
        },
        {
            "name": "Hypermolar syndrome",
            "percent": null
        },
        {
            "name": "Hypervolemia",
            "percent": null
        },
        {
            "name": "Phlebitis",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Polydipsia",
            "percent": null
        },
        {
            "name": "Pulmonary edema",
            "percent": null
        },
        {
            "name": "Cerebral hemorrhage",
            "percent": null
        },
        {
            "name": "Mental confusion",
            "percent": null
        },
        {
            "name": "unconsciousness",
            "percent": null
        },
        {
            "name": "Cerebral ischemia",
            "percent": null
        },
        {
            "name": "Hypophosphatemia",
            "percent": null
        },
        {
            "name": "Hypomagnesemia",
            "percent": null
        },
        {
            "name": "Hyperglycemia",
            "percent": null
        },
        {
            "name": "Injection site extravasation",
            "percent": null
        },
        {
            "name": "Tissue necrosis",
            "percent": null
        }
    ]
}